PharmBrief | Новости фармации

📈 Analytical overview of Telegram channel PharmBrief | Новости фармации

Channel PharmBrief | Новости фармации (@pharmbrief) in the Russian language segment is an active participant. Currently, the community unites 10 092 subscribers, ranking 2 731 in the Medicine category and 63 987 in the Russia region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 10 092 subscribers.

According to the latest data from 31 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -12 over the last 30 days and by 7 over the last 24 hours, overall reach remains high.

• Verification status: Not verified
• Engagement rate (ER): The average audience engagement rate is 25.56%. Within the first 24 hours after publication, content typically collects 12.98% reactions from the total number of subscribers.
• Post reach: On average, each post receives 2 580 views. Within the first day, a publication typically gains 1 310 views.
• Reactions and interaction: The audience actively supports content: the average number of reactions per post is 23.
• Thematic interests: Content is focused on key topics such as строка, вакцина, fda, минздрав, акрихин.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“Фарма одной строкой. Новости фармации и фармацевтики. Мы в Дзен - dzen.ru/pharmbrief Совместный проект t.me/PharmJokes и t.me/scitramon По рекламе писать в каналы по ссылкам выше”

Thanks to the high frequency of updates (latest data received on 01 August, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.